시장보고서
상품코드
1419100

세계 호흡기 세포 융합 바이러스 진단 시장 : 제품별, 방법별, 최종 사용자별, 국가별, 지역별 산업 분석 - 시장 규모, 시장 점유율 예측(2023년-2030년)

Respiratory Syncytial Virus Diagnostics Market, By Product, By Method, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

호흡기 세포 융합 바이러스 진단 시장 규모는 2022년 9억 3,189만 달러로 평가되었고 2023년부터 2030년까지 복합 연간 성장률(CAGR) 9.63%로 확대될 전망입니다.

호흡기 세포 융합 바이러스 진단 시장 - 시장 역학

호흡기 감염의 유병률 증가와 체외 진단제에 대한 높은 수요가 시장 수요를 촉진

시장 확대를 촉진하는 주요 요인은 호흡기 감염률 증가, 신생아 수 증가, 포인트 오브 케어 시설 및 체외 진단제에 대한 높은 수요입니다. 호흡기 감염의 수는 만성 질환의 세계 발생률과 함께 증가할 것으로 예상됩니다. 이러한 감염은 신속한 진단과 치료로 예방할 수 있는 신생아 사망의 주요 원인이 되었습니다. 세계 시장은 특히 2세 미만 소아에서 호흡기 세포 융합 바이러스 감염(RSV)의 이환율이 증가함에 따라 견인되고 있습니다.

또한 건강 관리 인프라 투자 증가와 자녀의 건강에 대한 부모의 관심 증가와 같은 요인도 있으며 시장은 순조롭게 확대되고 있습니다. 진단기술의 가용성과 조기진단에 의한 생존율의 높이에 대한 인식 증가도 시장개발에 긍정적인 영향을 미치고 있습니다. 상환 가이드라인, 계발 캠페인, 무료 진단 등 정부의 적극적인 프로그램도 시장 확대에 기여하고 있습니다.

호흡기 세포 융합 바이러스 진단 시장 - 세분화 분석 :

호흡기 세포 융합 바이러스 진단 세계 시장은 제품, 방법, 최종 사용자 및 지역에 따라 세분화됩니다.

제품은 키트 시약, 장비 등으로 분류됩니다 : 시장을 독점하는 것은 키트 시약 부문입니다. RSV 항원검사용 키트시약 수요 증가가 시장 성장을 끌어올릴 것으로 예상됩니다.

시장은 방법에 따라 7가지 범주로 분류된다: 항원 신속 진단법(RADT), 분자진단법, 크로마토그래프 면역 측정법, 영상 진단법, 젤 마이크로 드롭렛, 유동 세포측정법 등. 크로마토그래프 면역측정법이 시장을 독점하고 있으며, 예측 기간 동안에도 그 우위성을 유지할 것으로 보입니다. 항원 신속 진단 검사(RADT)는 COVID-19의 우려로 최근 수요가 높습니다.

시장은 최종 사용자별로 병원, 재택치료 및 클리닉 등 3가지로 분류된다 . 재택 케어 및 클리닉 부문은 실험실 조사 및 검사 요구가 높기 때문에 예측 기간 동안 높은 복합 연간 성장률(CAGR) 성장할 것으로 예측됩니다.

호흡기 세포 융합 바이러스 진단 시장 - 지리적 인사이트

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 전개하는 국가에 따라 더 나뉩니다.

호흡기 세포 융합 바이러스 진단 시장 - 경쟁 구도 :

RSV 진단 약물 시장은 매우 경쟁이 심합니다. 제품 포트폴리오를 개선하고 제공하는 제품의 매력을 높이기 위해 주요 기업은 M&A 및 신제품 소개와 같은 전략을 채택하고 있습니다. 각 회사는 더 나은 검사를 위해 새로운 호흡기 패널을 개발하기 위해 노력하고 있습니다. 이 시장의 주요 기업은 Novartis AG, Abbott, La Roche 등을 포함합니다.

목차

제1장 호흡기 세포 융합 바이러스 진단 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 호흡기 세포 융합 바이러스 진단의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 호흡기 세포 융합 바이러스 진단의 업계의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀의 분석

제5장 호흡기 세포 융합 바이러스 진단 시장 : COVID-19의 영향 분석

  • 신형 코로나바이러스 감염증 이전의 영향 분석
  • 신형 코로나바이러스 감염증 후의 영향 분석

제6장 호흡기 세포 융합 바이러스 진단 시장 상황

  • 호흡기 세포 융합 바이러스 진단 시장 점유율 분석(2022년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥 기업의 분석

제7장 호흡기 세포 융합 바이러스 진단 시장 - 제품별

  • 개요
    • 제품별 부문 점유율 분석
    • 키트 및 시약
    • 기기
    • 기타

제8장 호흡기 세포 융합 바이러스 진단 시장-방법별

  • 개요
    • 부문 점유율 분석(방법별)
    • 신속 항원 진단 검사(RADT)
    • 분자진단학
    • 크로마토그래피 면역 측정법
    • 영상 진단
    • 젤 미세 액적
    • 플로우 사이토메트리
    • 기타

제9장 호흡기 세포 융합 바이러스 진단 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원
    • 홈케어와 클리닉
    • 기타

제10장 호흡기 세포 융합 바이러스 진단 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 호흡기 세포 융합 바이러스 진단 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • QIAGEN
    • Becton, Dickinson, and Company
    • Novartis AG
    • Abbott
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Quest Diagnostics
    • F. Hoffmann-La Roche Ltd.
    • BIOMERIEUX
    • DiaSorin SpA
    • Merck KGaA
    • Quidel Corporation
    • Coris BioConcept
    • Siemens Healthcare SA
    • Others

제12장 애널리스트의 전방위 전망

BJH 24.02.13

REPORT HIGHLIGHT

Respiratory Syncytial Virus Diagnostics Market size was valued at USD 931.89 Million in 2022, expanding at a CAGR of 9.63% from 2023 to 2030.

For Respiratory Syncytial Virus (RSV), rapid RSV antigen tests are the most often used test. They look for specific proteins from the RSV virus known as antigens in a fluid sample taken from your nose. RSV antigens cause the virus to be attacked by your immune system.

Respiratory Syncytial Virus Diagnostics Market- Market Dynamics

Increasing prevalence of respiratory infections and high demand for in-vitro diagnostics to propel market demand

The main drivers propelling the market expansion are the rising rate of respiratory infections, the growing number of newborns, and the high demand for point-of-care facilities and in-vitro diagnostics. It is predicted that the number of respiratory infections will rise along with the global incidence of chronic illnesses. These infections are a major cause of death in newborns, although they can be prevented with prompt diagnosis and treatment. The worldwide market is being driven by the increasing incidence of respiratory syncytial virus diagnostic (RSV) sickness, especially in children under the age of two years.

Furthermore, due to the factors like rising healthcare infrastructure investments and parents' growing concern for their children's health, the market is growing favorably. The availability of diagnostic technologies and growing awareness of the great survival rates that follow early diagnosis are also having a favorable effect on the market's development. Positive government programs, such as reimbursement guidelines, awareness campaigns, and free diagnostics, among others, contribute to the market's expansion.

Respiratory Syncytial Virus Diagnostics Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.63% over the forecast period (2023-2030)
  • Based on Product segmentation, kits & reagents segment was predicted to show maximum market share in the year 2022, owing to high demand for smaller kits in RSV antigen testing.
  • Based on Method segmentation, chromatographic immunoassay segment was predicted to show maximum market share in the year 2022, owing to high demand for molecular diagnostics.
  • Based on End-User segmentation, hospitals segment was the leading segment in 2022, mainly due to increasing number of RSV infections.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to increasing infant population.

Respiratory Syncytial Virus Diagnostics Market- Segmentation Analysis:

The Global Respiratory Syncytial Virus Diagnostics Market is segmented on the basis of Product, Method, End-User, and Region.

The market is divided into three categories based on Product: kits & reagents, instruments, and others. The kits & reagents segment dominates the market. Increasing demand for kits & reagents for RSV antigen tests is expected to boost the market growth.

The market is divided into seven categories based on Method: rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others. The chromatographic immunoassay segment dominates the market and is likely to maintain its dominance during the forecast period. The rapid antigen diagnostic test (RADTs) has witnessed high demand in recent years due to COVID-19 concerns.

The market is divided into three categories based on End-User: hospitals, homecare & clinics, and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. The homecare & clinics segment is expected to grow at a significant CAGR over the forecast period due to high need for laboratory research and testing.

Respiratory Syncytial Virus Diagnostics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Respiratory Syncytial Virus Diagnostics Market- Competitive Landscape:

RSV diagnostics market is highly competitive as the industry is seen as being extremely competitive. To improve their product portfolios and increase the attractiveness of their offerings, the major players employ strategies like mergers and acquisitions and the introduction of new products. The companies engage in developing new respiratory panels for better testing. Key player in the market includes Novartis AG, Abbott, La Roche, etc.

Recent Developments:

In November 2021, QIAGEN introduced and obtained CE-marking for the QIAstat-Dx Respiratory 4 Plex Flu A-B/RSV/SARS-CoV-2 test.

In September 2021, La Roche introduced a collection of three PCR diagnostic test panels based on molecular polymerase chain reaction technology. These panels are precisely designed to concurrently detect and distinguish various common respiratory pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET KEY PLAYERS

  • QIAGEN
  • Becton, Dickinson, and Company
  • Novartis AG
  • Abbott
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Quest Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • BIOMERIEUX
  • DiaSorin S.p.A.
  • Merck KGaA
  • Quidel Corporation
  • Coris BioConcept
  • Siemens Healthcare S.A.
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET, BY PRODUCT

  • Kits & reagents
  • Instruments
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET, BY METHOD

  • Rapid Antigen Diagnostic Test (RADTs)
  • Molecular diagnostics
  • Chromatographic immunoassay
  • Diagnostic imaging
  • Gel microdroplets
  • Flow cytometry
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET, BY END-USER

  • Hospitals
  • Homecare & clinics
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Respiratory Syncytial Virus Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Respiratory Syncytial Virus Diagnostics Market Snippet by Product
    • 2.1.2. Respiratory Syncytial Virus Diagnostics Market Snippet by Method
    • 2.1.3. Respiratory Syncytial Virus Diagnostics Market Snippet by End-User
    • 2.1.4. Respiratory Syncytial Virus Diagnostics Market Snippet by Country
    • 2.1.5. Respiratory Syncytial Virus Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Respiratory Syncytial Virus Diagnostics Key Market Trends

  • 3.1. Respiratory Syncytial Virus Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Respiratory Syncytial Virus Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Respiratory Syncytial Virus Diagnostics Market Opportunities
  • 3.4. Respiratory Syncytial Virus Diagnostics Market Future Trends

4. Respiratory Syncytial Virus Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Respiratory Syncytial Virus Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Respiratory Syncytial Virus Diagnostics Market Landscape

  • 6.1. Respiratory Syncytial Virus Diagnostics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Respiratory Syncytial Virus Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 7.1.2. Kits & reagents
    • 7.1.3. Instruments
    • 7.1.4. Others

8. Respiratory Syncytial Virus Diagnostics Market - By Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Method, 2022 & 2030 (%)
    • 8.1.2. Rapid Antigen Diagnostic Test (RADTs)
    • 8.1.3. Molecular diagnostics
    • 8.1.4. Chromatographic immunoassay
    • 8.1.5. Diagnostic imaging
    • 8.1.6. Gel microdroplets
    • 8.1.7. Flow cytometry
    • 8.1.8. Others

9. Respiratory Syncytial Virus Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Homecare & clinics
    • 9.1.4. Others

10. Respiratory Syncytial Virus Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Respiratory Syncytial Virus Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Respiratory Syncytial Virus Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Respiratory Syncytial Virus Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Respiratory Syncytial Virus Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Respiratory Syncytial Virus Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Respiratory Syncytial Virus Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. QIAGEN
    • 11.2.2. Becton, Dickinson, and Company
    • 11.2.3. Novartis AG
    • 11.2.4. Abbott
    • 11.2.5. Ortho Clinical Diagnostics
    • 11.2.6. Thermo Fisher Scientific Inc.
    • 11.2.7. Bio-Rad Laboratories, Inc.
    • 11.2.8. Quest Diagnostics
    • 11.2.9. F. Hoffmann-La Roche Ltd.
    • 11.2.10. BIOMERIEUX
    • 11.2.11. DiaSorin S.p.A.
    • 11.2.12. Merck KGaA
    • 11.2.13. Quidel Corporation
    • 11.2.14. Coris BioConcept
    • 11.2.15. Siemens Healthcare S.A.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제